Public-private effort set to generate X-Man cell lines for research

11/22/2011 | Genetic Engineering & Biotechnology News

Horizon Discovery signed a three-year agreement with the National Human Genome Research Institute and the National Cancer Institute allowing researchers access to its Genesis rAAV gene-editing technology to generate cell lines for basic and translational research. NHGRI and Horizon researchers will develop isogenic disease models of melanoma. NCI will also develop disease models for research and establish a center for excellence in gene editing.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI